The performed in vivo imaging and ex vivo biodistribution studies indicated a contribution of both peptides of the evaluated HBPL to overall in vivo tumor uptake, showing the feasibility of the general concept to develop GRPR- and NPY(Y1)R-bispecific PET radiotracers with regard to an improved and more sensitive tumor visualization of human breast cancer. This evidence concerns the gene GRPR and breast cancer.